Exosome drug delivery system and preparation method and application thereof

A delivery system and exosome technology, applied in the field of medicine, can solve the problem of low drug loading, and achieve the effects of good biocompatibility, good safety, and acid resistance.

Active Publication Date: 2021-08-24
天津外泌体科技有限公司
View PDF4 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At this stage, the drug loading of exosomes as delivery vehicl...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Exosome drug delivery system and preparation method and application thereof
  • Exosome drug delivery system and preparation method and application thereof
  • Exosome drug delivery system and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0043] The preparation method of cisplatin prodrug, concrete steps are as follows:

[0044] Step 1 uses H at a concentration of 30% (W / V) 2 o 2 Activate cisplatin (CDDP), the reaction temperature is 55-80°C, stir in the dark for 4.5-7.5h, cool at 4°C for 2h, filter under reduced pressure to obtain a light yellow solid, and wash with water, ethanol, and ether in sequence to obtain di Hydroxydiamine dichloroplatinum;

[0045]

[0046] Step 2 uses 4-dimethylaminopyridine (DMAP) as a catalyst to react dihydroxydiamine dichloroplatinum with succinic anhydride, and the molar ratio of dihydroxydiamine dichloroplatinum to succinic anhydride is 1:1-3; The temperature is 60-80°C, stirring for 3 hours to obtain succinic acid hydroxydiamine dichloroplatinum;

[0047] Step 3 uses N-hydroxysuccinimide (NHS) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) as a catalyst to convert succinic acid hydroxydiamine di Chloroplatinum and phosphatidylethanolamine underg...

Embodiment 1

[0058] Embodiment 1: the preparation of cisplatin prodrug

[0059] Synthesis of dihydroxy diamine dichloroplatinum: CDDP (2g) and 30ml 30% hydrogen peroxide (w / v) were added to a round bottom flask, stirred at 70°C in the dark for 6 hours, cooled at 4°C for 2 hours, and decompressed Light yellow crystals were obtained by filtration, washed with water, ethanol and ether respectively, and dried to obtain the product dihydroxydiammine dichloroplatinum.

[0060] Synthesis of cisplatin prodrug: In a round bottom flask, dihydroxydiamine dichloroplatinum (100 mg, 0.3 mmol) and succinic anhydride (300 mg, 0.3 mmol) were added, dissolved in (DMF), and 4-dimethyl Aminopyridine (DMAP, 0.3 mmol). Stir at 75°C for 3 hours. After the reaction, add water to precipitate a light yellow solid; then wash with water and petroleum ether to obtain the product.

[0061] The above yellow solid of Pt(IV) (129 mg, 0.3 mmol) was dissolved in ultrapure water, and EDC (34 mg, 0.3 mmol) and NHS (56.7 m...

Embodiment 2

[0062] Example 2: Detection of fusion efficiency of DSPE liposomes and milk exosomes

[0063] Dissolve DSPE in 1ml CH 3 OH, N 2 Blow dry the solvent and vacuum dry for 24h. Then add 2ml of PBS solution to ultrasonically dissolve, then repeatedly extrude 20 times through a 30nm extruder to collect DSPE liposomes. Use DID dye to stain the liposome membrane, and use a 10KD ultrafiltration tube to remove unbound DID dye to obtain red-stained DSPE liposomes. Liposomes were characterized morphologically by TEM (Transmission electron microscopy), and the proportion of stained liposomes in the total was detected by nano flow cytometry. Such as figure 1 As shown, the particle size distribution of the prepared liposomes was all about 30nm, and the distribution was uniform, and the results of nano flow cytometry showed that 87.5% of the liposomes were successfully stained.

[0064] Milk exosomes were separated from fresh milk by acid precipitation, centrifugation, and ultracentrifug...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an exosome drug delivery system as well as a preparation method and application thereof, provides an active drug loading system for loading a cis-platinum prodrug on an exosome by utilizing a phospholipid compound, and solves the problems of membrane rupture, low drug loading capacity and the like caused by an exosome drug loading strategy. According to the invention, the cis-platinum prodrug is prepared in advance and is prepared into the liposome, and then the liposome is mixed with the exosome to realize active drug loading, so that the fusion effect of the phospholipid compound and the exosome membrane is utilized, the completeness of the exosome membrane is protected, and the drug loading capacity of the exosome to the anti-cancer drug is improved.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to an exosome drug delivery system and its preparation method and application. Background technique [0002] Exosomes are small vesicles with a diameter of 30-150nm in a saucer-shaped structure, which contain RNA, protein, microRNA, DNA fragments and other components. All eukaryotic cells and some prokaryotic cells can secrete it, and it is mainly distributed in various body fluids such as blood, saliva, urine, amniotic fluid and breast milk. It is the early endosome formed by the invagination of the plasma membrane of the cell, and the encapsulation material of the endosome forms a multivesicular body, and then the multivesicular body is released after fusion with the plasma membrane. It is the structure (phospholipid bilayer and vesicle-like structure) and physiological properties of exosomes that make them biocompatible. And exosomes can freely cross the blood-brai...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07F15/00A61K33/243A61K47/54A61K47/69A61P35/00
CPCA61K47/544A61K47/6901A61K47/6911A61P35/00A61K33/243C07B2200/07C07F15/0093
Inventor 葛啸虎程国钢王达陆路王淼韩春乐陈宁马德美
Owner 天津外泌体科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products